Table_8_Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.XLSX by Chong Shuai (9419732)

“…</p><p>Results: High levels of ER decreased the expression of IL-17A, IL-17C, and IL-17F but increased the expression of IL-17E (IL25), which acts as a suppressor of IL-17 signaling. …”

Table_6_Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.XLSX by Chong Shuai (9419732)

“…</p><p>Results: High levels of ER decreased the expression of IL-17A, IL-17C, and IL-17F but increased the expression of IL-17E (IL25), which acts as a suppressor of IL-17 signaling. …”

Table_2_Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.XLSX by Chong Shuai (9419732)

“…</p><p>Results: High levels of ER decreased the expression of IL-17A, IL-17C, and IL-17F but increased the expression of IL-17E (IL25), which acts as a suppressor of IL-17 signaling. …”

Table_3_Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.XLSX by Chong Shuai (9419732)

“…</p><p>Results: High levels of ER decreased the expression of IL-17A, IL-17C, and IL-17F but increased the expression of IL-17E (IL25), which acts as a suppressor of IL-17 signaling. …”

Table_1_Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.XLSX by Chong Shuai (9419732)

“…</p><p>Results: High levels of ER decreased the expression of IL-17A, IL-17C, and IL-17F but increased the expression of IL-17E (IL25), which acts as a suppressor of IL-17 signaling. …”

Earlier Age at Type 2 Diabetes Diagnosis Is Associated with Increased Genetic Risk for Cardiovascular Disease by Hyunsuk Lee (2057740)

“…In UK Biobank, effect size of coronary artery disease (CAD) PRS on incident CAD was largest in people diagnosed of T2D at ages 30-39 (hazard ratio 2.25, 95% CI 1.56-3.26) and decreased for later-onset: 1.51 (1.30-1.75) at 40-49, 1.36 (1.24-1.50) at 50-59, and 1.30 (1.14-1.48) at 60-69 (<em>P</em>interaction=0.0031). …”

Life-history plasticity of intertidal salt marsh in response to sea level rise: Salinity and inundation modulate size-dependent flowering of <i>Spartina alterniflora</i> by Jiayu Wang (21577321)

Data_Sheet_1_Low Non-structural Carbon Accumulation in Spring Reduces Growth and Increases Mortality in Conifers Defoliated by Spruce Budworm.PDF by Angelo Fierravanti (8541531)

“…Under conditions of increased defoliation, carbon allocation to reserves and radial growth decreased in a similar manner for both species. Starch concentration within twigs and needles in May and June was the best indicator of carbon status in defoliated trees. …”

lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis by Wenchang Ni (7907711)

“…We also found that ZFPM2-AS1 targets miR-511-3p to upregulate PAX6 in Y79 and SO-RB50 cells. …”

Image3_Sanguinarine protects against indomethacin-induced small intestine injury in rats by regulating the Nrf2/NF-κB pathways.TIF by Xiu-lian Lin (13935582)

Image1_Sanguinarine protects against indomethacin-induced small intestine injury in rats by regulating the Nrf2/NF-κB pathways.TIF by Xiu-lian Lin (13935582)

Image2_Sanguinarine protects against indomethacin-induced small intestine injury in rats by regulating the Nrf2/NF-κB pathways.TIF by Xiu-lian Lin (13935582)

Image10_Sanguinarine protects against indomethacin-induced small intestine injury in rats by regulating the Nrf2/NF-κB pathways.TIF by Xiu-lian Lin (13935582)

Suppl Fig 1.pdf by Daniel Devor (13515583)

“…TRAM-34 significantly decreased Ca and increased Cb. The`X±SEM values are shown above the individual data points. (#, P<0.01).…”

Image_1_Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.jpeg by Jiansheng Lin (1473871)

“…The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. …”

Table_2_Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.docx by Jiansheng Lin (1473871)

“…The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. …”

Image_2_Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.jpeg by Jiansheng Lin (1473871)

“…The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. …”

Table_1_Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.docx by Jiansheng Lin (1473871)

“…The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. …”

Table_3_Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.docx by Jiansheng Lin (1473871)

“…The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. …”

Table_4_Epidemiological Characteristics of Primary Liver Cancer in Mainland China From 2003 to 2020: A Representative Multicenter Study.docx by Jiansheng Lin (1473871)

“…The proportions of HCC and HBV seropositivity increased, whereas that of anti-HCV decreased, from 2003 to 2020. Postoperative five-year survival rate was 73.5%, 64.1%, 34.9%, and 19.7% in HCC at BCLC stage 0, A, B, and C, respectively. …”